Webinar: CGT is Getting More Complex. Digital Operations Are Struggling to Keep Up

The CGT operating model built in 2017 was never designed for today's multi-modality portfolio. Read the brief, then join the live conversation on June 11.

As CGT programs scale across sites, therapy types, and portfolios, the coordination layer holding them together is starting to fracture. Join senior operators from across biotech, treatment centres, and supply chain leadership for a discussion on where programs actually fail and what commercially ready organisations are doing differently.

📅 Thursday June 11 ⏰ 11:00 ET / 16:00 UK / 17:00 CET

11 Jun 2026
|
Webinar: CGT is Getting More Complex. Digital Operations Are Struggling to Keep Up

Join senior operators from across biotech, treatment centres, and supply chain leadership for a discussion on where programs actually fail and what commercially ready organisations are doing differently.

From chain-of-identity and chain-of-custody pressures to fragmented digital infrastructure and governance gaps, this session will explore the operational realities emerging as advanced therapies move beyond the industry's first-wave operating models.

Co-hosted by Phacilitate and BlueSquared, the discussion brings together leaders working directly across CGT operations, manufacturing, treatment centre coordination, and digital enablement to unpack where friction is increasing and how organisations are adapting before those issues become commercial bottlenecks.

What you will leave with:

  • A clearer understanding of where coordination failures actually happen across CGT programs
  • Insight into why orchestration is becoming a distinct operational discipline in advanced therapies
  • Practical perspectives from operators managing complexity across sites, modalities, and stakeholder groups
  • A live view of how the audience scores across key operational maturity domains
  • Access to BlueSquared's CGT Digital Orchestration Maturity Assessment, including a personalised 10-page report with maturity radar, gap analysis, and a 30-day action plan

Who should attend: This session is designed for senior professionals across:

  • Cell and Gene Therapy Operations
  • Patient Operations
  • CGT Supply Chain and Logistics
  • Digital and IT for Advanced Therapies
  • CMC and Manufacturing Operations
  • Quality and Governance
  • Treatment Centre Operations

Webinar format:

  • 60-minute online webinar
  • Moderated practitioner panel
  • Live audience polling and maturity diagnostic
  • Interactive Q&A
  • Co-hosted by Phacilitate and BlueSquared

Register now

Contributors
Speaker 1 Image
Becky Johnson-Kent (Moderator)
Global Event Director, Phacilitate
Becky will be moderating the session, bringing deep expertise in convening senior leaders across the advanced therapies ecosystem.
Speaker 2 Image
Anthony Roth
CEO, BlueSquared
Anthony spent five years inside Roche's CGTi program evaluating, building, and making calls on the technology stack. Twenty years before that, he delivered enterprise software across Oracle, Gilead, and Roche. He has been on both sides of the table when CGT programs make technology decisions.
Speaker 3 Image
J. Andrew Case
Head of Supply Chain Cell & Gene Therapies, Genentech/Roche
Andrew sat inside the first commercial CAR-T launch at Novartis, where he built the orchestration platform that ran Kymriah through its first commercial launch. He knows firsthand what the first-wave playbook assumed and where those assumptions stop holding as programmes scale.
Speaker 4 Image
Arthur Malian
Senior Cell Therapy Operations, Bayrose Consulting
Art built and ran the digital infrastructure at BMS that carried two commercial cell therapy products through regulatory approval across four markets, enabling treatment for over 6,500 patients.
Speaker 5 Image
Ronit Slotky PhD
Director, Hackensack University Medical Center
Ronit directs the cell therapy manufacturing facility that receives and runs programmes from multiple sponsors simultaneously. She brings the treatment centre perspective that most sponsor-side conversations never hear.
View all Insights & Resources
Loading